Maxim M. Bespalov - Concepedia

Author

Maxim M. Bespalov

University of Helsinki ORCID

Also Known As

M. Bespalov, M. M. Bespalov, M.M. Bespalov, Maxim Bespalov, Maxim M Bespalov, Maxim M. Bespalov, Maxim M. BESPALOV

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Institute for Molecular Medicine Finland Helsinki University Hospital Biocenter Finland University of Tartu

About

Maxim M. Bespalov is an author at University of Helsinki specializing in medicine, molecular physiology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	771
2	Health Sciences	1	1	36
3	Natural Sciences	1	1	68
4	Social Sciences	1	1	198
5	Biology	1	1	27

Maxim M. Bespalov

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia Tea Pemovska, Mika Kontro, Bhagwan Yadav, Cancer Discovery	2013	401
Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses Finny S. Varghese, Pasi Kaukinen, Sabine Gläsker, Antiviral Research MedicinePathogenesisOther AlphavirusesAntiviral ResponseAntiviral Drug Development	2016	208
Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin Maxim M. Bespalov, Yulia Sidorova, Sarka Tumova, The Journal of Cell Biology Synaptic TransmissionGlycobiologyImmunologyPathologyCellular Neurobiology	2011	198
Human pluripotent reprogramming with CRISPR activators Jere Weltner, Diego Balboa, Shintaro Katayama, Nature Communications	2018	176
Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism Suvi Kuivanen, Maxim M. Bespalov, Jatin Nandania, Antiviral Research Affect Cellular SignalingMedicinePathogenesisAntiviral Drug DevelopmentVirology	2017	105
The Structure of the Glial Cell Line-derived Neurotrophic Factor-Coreceptor Complex Vimal Parkash, Veli‐Matti Leppänen, Heidi Virtanen, Journal of Biological Chemistry	2008	82
The structure of GFRα1 domain 3 reveals new insights into GDNF binding and RET activation Veli‐Matti Leppänen, Maxim M. Bespalov, Pia Runeberg‐Roos, The EMBO Journal Ret ActivationSignal TransductionMolecular PhysiologySignaling PathwayMolecular Regulation	2004	68
Lack ofl-Iduronic Acid in Heparan Sulfate Affects Interaction with Growth Factors and Cell Signaling Juan Jia, Marco Maccarana, Xiao Zhang, Journal of Biological Chemistry	2009	61
Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons Marjo Piltonen, Maxim M. Bespalov, Dagmar Ervasti, Experimental Neurology Tissue DistributionNeuropharmacologyHeparin-binding DeterminantsNeuroprotectionNeurology	2009	48
Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease Pia Runeberg‐Roos, Elisa Piccinini, Anna‐Maija Penttinen, Neurobiology of Disease Neurodegenerative DiseasesEfficient Neurturin VariantsMedicineNeurologyNeuroscience	2016	45

Page 1